Dianthus Therapeutics, INC /DE/ DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Dianthus Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 21, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.
NASDAQ
Dianthus Therapeutics announces its annual stockholder meeting to be held on May 22, 2025, with proxy materials available online.
NASDAQ
Dianthus Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on May 22, 2025, featuring director elections, executive compensation advisory vote, and ratification of the independent accounting firm.
NASDAQ
Dianthus Therapeutics will hold its annual stockholder meeting on May 23, 2024, to vote on director elections, executive compensation, and other key proposals.
NASDAQ
DEF 14A: Dianthus Therapeutics Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Dianthus Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on May 23, 2024, featuring proposals including director elections, executive compensation, and ratification of the independent accounting firm.